Writing a PBRER That Passes EMA Review: The Sections Most Teams Get Wrong All Category, Blogs, Medical Writing, Pharmacovigilance, regulatory / development / April 13, 2026 Writing a PBRER That Passes EMA Review: The Sections Most Teams Get Wrong Read More »
Cell & Gene Therapy in the EU: EMA’s ATMP Regulatory Pathway Unpacked for Manufacturers All Category, Blogs, Clinical Regulatory, Pharmacovigilance, regulatory / Nikita Saraswat / April 13, 2026 Cell & Gene Therapy in the EU: EMA’s ATMP Regulatory Pathway Unpacked for Manufacturers Read More »
Toxicology Strategy in Drug & Device Development: From ICH S Guidelines to Regulatory Dossiers All Category, Blogs, Clinical Regulatory, GMP Compliance, Pharmacovigilance / development / March 23, 2026 Toxicology Strategy in Drug & Device Development: From ICH S Guidelines to Regulatory Dossiers Read More »
Drug Safety Just Got Smarter: Inside the EMA’s 2026 GVP Updates Overhaul All Category, Blogs, Pharmacovigilance / development / March 2, 2026 Drug Safety Just Got Smarter: Inside the EMA’s 2026 GVP Updates Overhaul Read More »
Inspection Findings Related to Vendor Oversight in Pharmacovigilance All Category, Blogs, Pharmacovigilance / Nikita Saraswat / February 27, 2026 Inspection Findings Related to Vendor Oversight in Pharmacovigilance Read More »
Risk Management Plans: Structure, Maintenance, and Regulatory Triggers for Updates All Category, Blogs, Pharmacovigilance / development / February 24, 2026 Risk Management Plans: Structure, Maintenance, and Regulatory Triggers for Updates Read More »
Signal Detection in Pharmacovigilance: Regulatory Expectations and Tools All Category, Blogs, Pharmacovigilance, regulatory / development / February 11, 2026 Signal Detection in Pharmacovigilance: Regulatory Expectations and Tools Read More »
Regulatory Requirements for Post-Authorization Safety Studies (PASS) All Category, Blogs, Pharmacovigilance / development / February 4, 2026 Regulatory Requirements for Post-Authorization Safety Studies (PASS) Read More »
Cultural Nuances in Adverse Event Reporting: Why Patient-Reported Outcomes Inconsistent Globally All Category, Blogs, Pharmacovigilance / development / January 30, 2026 Cultural Nuances in Adverse Event Reporting: Why Patient-Reported Outcomes Inconsistent Globally Read More »
Automation in Pharmacovigilance: Reducing Errors and Improving Efficiency All Category, Blogs, Pharmacovigilance / development / December 15, 2025 Automation in Pharmacovigilance: Reducing Errors and Improving Efficiency Read More »
